NorthWest Health Prop Real Est Inv Trust ( TSE:NWH.UN – Get Free Report ) was downgraded by investment analysts at Cormark from a 'buy' rating to a 'market perform' rating in a research note issued on Monday, BayStreet.CA reports. They presently have a C$9.50 target price on the stock, down from their prior target price of C$10.50. Cormark's target price indicates a potential upside of 51.76% from the company's previous close. Several other analysts also recently weighed in on NWH.UN. CIBC downgraded NorthWest Health Prop Real Est Inv Trust from an 'outperform' rating to a 'neutral' rating and dropped their price objective for the stock from C$11.

https://www.dailypolitical.com/2023/08/21/cormark-lowers-northwest-health-prop-real-est-inv-trust-tsenwh-un-to-market-perform.html

#dailypolitical